Skip to main content


Media Coverage

Stem Cell Letter Could Signal New FDA Enforcement Trend

21 January 2016
In a bylined article, Litigation & Dispute Resolution partners Mark Mansour, Christopher Mikson, and associate Emily Strunk (all Washington DC) discuss a stem cell warning letter sent by the FDA signaling an increased enforcement trend.

Related Information

  • Related People
    Christopher M. Mikson, MD
    T +1 202 263 3157
    Emily K. Strunk
    T +1 202 263 3404
The Build a Report feature requires the use of cookies to function properly. Cookies are small text files that are placed on your computer by websites that you visit. They are widely used in order to make websites work, or work more efficiently. If you do not accept cookies, this function will not work. For more information please see our Privacy Policy

You have no pages selected. Please select pages to email then resubmit.